(Q44192084)

30 November 2017

Large nontransplanted hepatocellular carcinoma in woodchucks: treatment with adenovirus-mediated delivery of interleukin 12/B7.1 genes (English)

1 reference

30 November 2017

1 reference

hepatocellular carcinoma

1 reference

4

1 reference

30 November 2017

9

Tennant B

1 reference

30 November 2017

Pützer BM

1

1 reference

30 November 2017

Stiewe T

2

1 reference

30 November 2017

Rödicker F

3

1 reference

30 November 2017

Rühm S

5

1 reference

30 November 2017

Dirsch O

6

1 reference

30 November 2017

Fiedler M

7

1 reference

30 November 2017

Damen U

8

1 reference

30 November 2017

Scherer C

10

1 reference

30 November 2017

Graham FL

11

1 reference

30 November 2017

Roggendorf M

12

1 reference

30 November 2017

language of work or name

English

0 references

publication date

1 March 2001

1 reference

Journal of the National Cancer Institute

30 November 2017

1 reference

30 November 2017

93

1 reference

30 November 2017

6

1 reference

30 November 2017

472-479

1 reference

The host-tumor immune conflict: from immunosuppression to resistance and destruction

30 November 2017

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.6.472

Immune selection in neoplasia: towards a microevolutionary model of cancer development

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.6.472

How tumors escape immune destruction and what we can do about it.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.6.472

Neuroblastoma regression and immunity induced by transgenic expression of interleukin-12.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.6.472

Intratumoral injection of an adenovirus expressing interleukin 2 induces regression and immunity in a murine breast cancer model

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.6.472

Intratumoral coinjection of adenoviral vectors expressing IL-2 and IL-12 results in enhanced frequency of regression of injected and untreated distal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.6.472

Direct Intratumoral Injection of an Adenovirus Expressing Interleukin-12 Induces Regression and Long-Lasting Immunity That Is Associated with Highly Localized Expression of Interleukin-12

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.6.472

Interleukin 12 and B7-1 costimulatory molecule expressed by an adenovirus vector act synergistically to facilitate tumor regression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.6.472

Combination therapy with interleukin-2 and wild-type p53 expressed by adenoviral vectors potentiates tumor regression in a murine model of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.6.472

Interleukin-12 and its role in the generation of TH1 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.6.472

Inhibition of angiogenesis in vivo by interleukin 12.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.6.472

Interleukin-12 and B7.1 co-stimulation cooperate in the induction of effective antitumor immunity and therapy of established tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.6.472

Tumour cell expression of B7 costimulatory molecules and interleukin-12 or granulocyte-macrophage colony-stimulating factor induces a local antitumour response and may generate systemic protective immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.6.472

A reassessment of the role of B7-1 expression in tumor rejection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.6.472

Tumor-induced immune dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.6.472

The woodchuck: an animal model for hepatitis B virus infection in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.6.472

Woodchuck hepatitis virus-induced carcinoma as a relevant natural model for therapy of human hepatoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.6.472

Phenotypic patterns of preneoplastic and neoplastic hepatic lesions in woodchucks infected with woodchuck hepatitis virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.6.472

Characteristics of a human cell line transformed by DNA from human adenovirus type 5

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.6.472

Improved safety through tamoxifen-regulated induction of cytotoxic genes delivered by Ad vectors for cancer gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.6.472

Methods for construction of adenovirus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.6.472

Combined gene therapy with suicide gene and interleukin-12 is more efficient than therapy with one gene alone in a murine model of hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.6.472

Regression of colon cancer and induction of antitumor immunity by intratumoral injection of adenovirus expressing interleukin-12.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.6.472

Induction of antitumor immunity by direct intratumoral injection of a recombinant adenovirus vector expressing interleukin-12.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.6.472

Pre-existing immunity to adenovirus does not prevent tumor regression following intratumoral administration of a vector expressing IL-12 but inhibits virus dissemination

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.6.472

Adenovirus-mediated interleukin-12 gene therapy for metastatic colon carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.6.472

B cells inhibit induction of T cell-dependent tumor immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.6.472

Influence of interleukin 12 on p53 peptide vaccination against established Meth A sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.6.472

Posttranscriptional inhibition of class I major histocompatibility complex presentation on hepatocytes and lymphoid cells in chronic woodchuck hepatitis virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.6.472

Antigen presentation by MHC class I and its regulation by interferon gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.6.472

21 January 2018

Identifiers

DOI

10.1093/JNCI/93.6.472

1 reference

30 November 2017

1 reference